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rep
MaOBJECTIVES This paper systematically analyzed the performance of magnetic resonance (MR) perfusion to diagnose
coronary artery disease (CAD) with fractional ﬂow reserve (FFR) as the reference standard.
BACKGROUND Myocardial MR perfusion has passed the stage of a research technique and has demonstrated the ability
to detect functional or ischemic stenosis of coronary arteries. However, the evidence is limited to single-center studies
and small sample sizes.
METHODS We searched PubMed and Embase databases for all published studies that evaluated the accuracy of MR
perfusion to diagnose CAD versus FFR. We used an exact binomial rendition of the bivariate mixed-effects regression
model with test type as a random-effects covariate to synthesize the available data. Based on Bayes’ theorem, the
post-test probability was calculated to guide MR perfusion’s clinical utility.
RESULTS We identiﬁed 14 studies evaluating 1,073 arteries and 650 patients. The pooled sensitivity and speciﬁcity
were 0.90 (95% conﬁdence interval [CI]: 0.86 to 0.93) and 0.87 (95% CI: 0.82 to 0.90) at the patient level and 0.89
(95% CI: 0.83 to 0.92) and 0.86 (95% CI: 0.77 to 0.92) at the artery and territory levels, respectively. The area under the
summary receiver-operating characteristic at the patient level was 0.95 (95% CI: 0.92 to 0.96) and 0.93 (95% CI: 0.91
to 0.95) at the artery and territory levels, respectively. MR perfusion could increase the post-test probability of CAD
>80% in patients with a pre-test probability of >37% and can decrease post-test probability of CAD <20% with a
pre-test probability of <72%.
CONCLUSIONS With FFR as the reference standard, the diagnostic ability of MR perfusion to detect ischemic CAD
is high. (J Am Coll Cardiol Img 2014;7:1098–105) © 2014 by the American College of Cardiology Foundation.C oronary artery disease (CAD) continues tobe a major public health concern in devel-oped and developing countries. Revasculari-
zation effectively restores blood ﬂow, but the ﬁrst
step requires an accurate evaluation of myocardial
ischemia caused by epicardial coronary artery steno-
sis (1–3).
Myocardial perfusion imaging by single-photon
emission computed tomography has long been
applied routinely to evaluate blood supply. In recentm the Department of Medical Imaging, Jinan Military General Hospital,
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(MR) imaging, myocardial MR perfusion has demon-
strated its ability to detect myocardial ischemia (4,5).
Compared with single-photon emission computed
tomography and other new perfusion modalities,
such as positron emission tomography and com-
puted tomography perfusion, MR perfusion offers
several advantages, such as no attenuation artifacts,
high spatial resolution, and no radiation exposure
(6,7). A systematic understanding of the diagnosticJinan, Shandong Province, China. The authors have
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AB BR E V I A T I O N S
AND ACRONYM S
CAD = coronary artery disease
CI = conﬁdence interval
FFR = fractional ﬂow reserve
LR = likelihood ratio
MI = myocardial infarction
MR = magnetic resonance
QCA = quantitative coronary
angiography
sROC = summary receiver-
operating characteristic
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1099performance of MR perfusion, therefore, has impor-
tant practical signiﬁcance.
Meta-analyses have shown the high accuracy of MR
perfusion in diagnosing myocardial ischemia, using
quantitative coronary angiography (QCA) as the
reference standard (8,9). Although QCA offers a direct
visualization of stenotic lumen, it may not reliably
detect whether a stenosis leads to ischemia. Given
that fractional ﬂow reserve (FFR) is superior to QCA in
guiding revascularization (1,2), the purpose of our
study was to systematically analyze the diagnostic
performance of MR perfusion with FFR as the refer-
ence standard.SEE PAGE 1106METHODS
The meta-analysis was performed using a standard
protocol based on the MOOSE (Meta-analysis of
Observational Studies in Epidemiology) guidelines
(10) and the PRISMA (Preferred Reporting Items
for Systematic Reviews and Meta-analyses) state-
ment (11).
DATA SOURCES AND STUDY SELECTION. We
searched PubMed and Embase databases for all pub-
lished studies in the English language evaluating the
accuracy of MR perfusion with FFR as the reference
standard, by searching the terms “FFR or fractional
ﬂow reserve” and “magnetic resonance imaging or
MRI.” Additionally, references to previous systematic
reviews were screened. Two reviewers examined the
references independently to exclude duplicate or
overlapping data.
STUDY ELIGIBILITY. The inclusion criteria for studies
were as follows: 1) MR perfusion was used as a diag-
nostic test for ischemic CAD; 2) FFR served as the
standard reference and FFR <0.75 or <0.80 was
considered ischemic CAD; and 3) results were re-
ported in absolute numbers of true-positive, false-
positive, true-negative, and false-negative results, or
sufﬁciently detailed data were provided to derive
these numbers. The exclusion criteria were the study
included patients with a history of coronary artery
bypass graft surgery or percutaneous coronary inter-
vention and as retrospective studies.
DATA EXTRACTION. The following information was
extracted by 2 investigators independently: ﬁrst
author; year of publication; sex; age; body mass
index; separate prevalence of multivessel disease,
diabetes, and myocardial infarction (MI); type
and brand of machine used; perfusion sequence;
magnet strength; and true-positive/true-negative/false-positive/false-negative values. Data
were recorded separately, whenever avail-
able, at the patient and artery/territory levels.
The quality analysis of the study had to
conform to QUADAS (Quality Assessment of
Diagnostic Accuracy Studies) guidelines (12).
Two readers independently evaluated QUA-
DAS items for all included studies; if they
disagreed, a third reader adjudicated.
DATA SYNTHESIS AND STATISTICAL ANALYSIS.
Interobserver agreement was assessed by the
Cohen kappa test, and publication bias was
investigated using a regression line, as outlined by
Deeks et al. (13), with p < 0.10 for the slope coefﬁcient
indicating signiﬁcant asymmetry.
We used an exact binomial rendition of the bivar-
iate mixed-effects regression model with test type as
a random-effects covariate to synthesize the avail-
able data (14,15). Sensitivity and speciﬁcity were
calculated along with their 95% conﬁdence intervals
(CIs). Based on the parameters estimated by the
bivariate model, a hierarchical summary receiver-
operating characteristic (sROC) curve was con-
structed. The area under the sROC curve serves as a
global measure of test performance: less predictive
(0.5area under the sROC curve0.7); moderately
predictive (0.7area under the sROC curve0.9);
and highly predictive (0.9area under the sROC
curve1) (16).
We used the Cochran Q statistic and measured
inconsistency (I2) (percentage of total variance across
studies attributable to heterogeneity rather than
chance) for the detection of heterogeneity across
studies (17). Possible sources of heterogeneity were
pre-deﬁned based on sex, age, prevalence of multi-
vessel disease, prevalence of diabetes, prevalence
of MI, magnet strength, and data interpretation. Meta-
regression, a collection of statistical procedures
(weighted/unweighted linear, logistic regression), was
applied to evaluate the potential covariates of het-
erogeneity. Furthermore, the clinical or patient-
relevant utility of MR perfusion was evaluated using
the positive/negative likelihood ratio (LR) to calculate
the post-test probability based on Bayes’ theorem (18).
The sensitivity analysis was conducted by omitting
each reference and reanalyzing the data to test
whether any studies signiﬁcantly inﬂuenced the ﬁnal
results.
We applied the MIDAS module for STATA, version
12 (StataCorp, College Station, Texas), to perform the
analysis and construct the graphs and used SPSS,
version 16.0 (SPSS Inc., Chicago, Illinois), to calculate
kappa statistics.
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1100RESULTS
CHARACTERISTICS OF MR PERFUSION STUDIES.
Among the studies that met our inclusion criteria, 2
(19,20) were excluded because they reported pop-
ulations that potentially overlapped with an earlier
study (21). A total of 14 studies were ultimately
identiﬁed for the literature search and selection al-
gorithm (Figure 1, Table 1). Eight studies reported
data at the patient level, among which 5 studies
performed MR perfusion with a magnetic intensity of
1.5-T, 2 with 3.0-T, and 1 with 1.5-T and 3.0-T. Nine
studies contained effective information at the artery/
territory level, among which 6 studies performed MR
perfusion with a magnetic intensity of 1.5-T, 2 with
3.0-T, and 1 with 1.5-T and 3.0-T. Finally, 10 groups of
data at the patient level and 10 at the artery/territory
level were available for synthesizing data.
METHODOLOGICAL QUALITY. Our inter-rater reliability
for assessing quality items was perfect (kappa ¼
0.89). Online Table 1 summarizes the QUADAS items
of each study.
DATA SYNTHESIS AND STATISTICAL ANALYSIS. The
pooled sensitivity and speciﬁcity were 0.87 (95% CI:
0.84 to 0.91) and 0.87 (95% CI: 0.83 to 0.90), after duplicates removed
( n = 150)
Full-text articles
essed for eligibility
(n = 19)
Full-text articles excluded,
with reasons (n = 5)
1.   Not about FFR (n = 1)
2.   No detailed data (n = 1)
3.   Surgery (n = 1)
4.   Potential overlapping
      data (n = 2)
Records excluded after title
and abstract screening
(n = 131)
tudies included in
antitative synthesis
(meta-analysis)
(n = 14)
Additional records identified
through other sources
(n = 12)
re Search and Selection Algorithm
re ultimately identiﬁed. FFR ¼ fractional ﬂow reserve.respectively, at the patient level. Between-study dif-
ferences in the diagnostic performance of MR perfu-
sion were found for sensitivity (Q ¼ 16.41; I2 ¼ 45.2%;
p ¼ 0.06), but no signiﬁcant heterogeneity was
detected for speciﬁcity (Q ¼ 6.04; I2 ¼ 0.40%; p ¼
0.43). Because we noticed that the sensitivity of
Bernhardt et al. (22) with 1.5-T was signiﬁcantly
different from other studies, we omitted these data
and reanalyzed the remaining information to test
whether the data caused this phenomenon. The het-
erogeneity decreased greatly with sensitivity (Q ¼
4.19; I2 ¼ 0.00%; p ¼ 0.76) and speciﬁcity (Q ¼ 4.72;
I2 ¼ 0.00%; p ¼ 0.69). The pooled sensitivity and
speciﬁcity were 0.90 (95% CI: 0.86 to 0.93) and 0.87
(95% CI: 0.82 to 0.90), respectively, at the patient
level (Figure 2).
Overall, 1,073 arteries and 650 patients were
analyzed. The results showed that 26.75% of the ar-
teries (287 of 1,073; range 16.28% to 41.33%) and
45.69% of patients (297 of 650; range 25.29% to
73.27%) had hemodynamic CAD. No publication bias
could be detected at the patient and artery/territory
levels (p ¼ 0.18 and p ¼ 0.90, respectively).
Using the pre-speciﬁed potential factors of het-
erogeneity as covariates in the meta-regression with
the random-effects model, we found that the preva-
lence of multivessel disease (p < 0.001) and MI
(p < 0.001) were signiﬁcant predictors, but other
factors did not inﬂuence the diagnostic accuracy,
including age (p ¼ 0.76), sex (p ¼ 0.22), magnet
strength (p ¼ 0.57), quantitative or semiquantitative
data interpretation (p ¼ 0.87), threshold of FFR to
deﬁne an ischemic stenosis (p ¼ 0.33), and the prev-
alence of diabetes (p ¼ 0.88).
At the artery/territory level, the pooled sensitivity
and speciﬁcity were 0.89 (95% CI: 0.83 to 0.92) and
0.86 (95% CI: 0.77 to 0.92), respectively. Slight het-
erogeneity was found for sensitivity (Q ¼ 9.79; I2 ¼
18.29%; p ¼ 0.28), whereas the heterogeneity was
signiﬁcant for speciﬁcity (Q ¼ 59.46; I2 ¼ 86.55%;
p < 0.001). Online Figure 1 demonstrated the high
area under the sROC curve at both the patient and
artery/territory levels (0.95 [95% CI: 0.92 to 0.96]
and 0.93 [95% CI: 0.91 to 0.95], respectively).
The per-patient analysis revealed a positive LR of
6.70 (95% CI: 5.06 to 8.87) and a negative LR of 0.12
(95% CI: 0.08 to 0.16) for MR perfusion. Based on
Bayes’ theorem, Figure 3 illustrates the relationship
between pre-test and post-test probability of CAD,
which indicated that MR perfusion could increase
the post-test probability of CAD >80% in patients
with a pre-test probability of >37% and can decrease
post-test probability of CAD <20% with a pre-test
probability of <72%.
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1101A sensitivity analysis, conducted at both the patient
and artery/territory levels to investigate the inﬂuence
of each individual study on the overall meta-analysis
summary estimate, demonstrated that no study inﬂu-
enced the pooled sensitivity and speciﬁcity >0.02
(Online Figure 2).
DISCUSSION
Myocardial perfusion is critical to the supply of
oxygen and substrates for contractile function
(23). Generally, low myocardial perfusion can be
caused by epicardial coronary artery stenosis as
well as abnormal coronary microcirculation (24).
Accurate measurement of ischemic stenoses of the
epicardial coronary arteries is essential for reason-
able revascularization.
In previous meta-analyses with QCA as the refer-
ence standard, MR perfusion offered comparatively
high accuracy for CAD detection, with a sensitivity of
0.89 (8) and 0.91 (9), and a speciﬁcity of 0.76 (8) and
0.81 (9). The present analysis indicates that with
FFR as the standard reference, the speciﬁcity (0.87)
of MR perfusion increases, whereas the sensitivity
(0.90) is similar. The improved speciﬁcity may stem
from a lower rate of false-positive reports of arteries
with no functional ﬂow limitation despite appearing
stenotic on QCA (25,26).
In this study, we estimated the relationship be-
tween pre-test and post-test probability of CAD based
on Bayes’ theorem to guide the clinical utility of MR
perfusion. The result indicates that for patients with a
low pre-test probability of CAD, MR perfusion could
be applied as an exclusionary test. Although nonin-
vasive MR perfusion may avoid potential iatrogenic
complications and unnecessary costs (26), MR perfu-
sion requires that the endocardial and epicardial
borders of the left ventricular wall be detected or
traced for each image frame of a perfusion study, a
time-consuming step for quantitative analysis (27). In
addition to the symptoms caused by vasodilator
stress agents (e.g., adenosine) during stress MR
perfusion, MR perfusion may not be a preferred
noninvasive test for patients with a low pre-test
probability of CAD (27). For patients with a high pre-
test probability of CAD, MR perfusion may be
applied as a conﬁrmatory test. Nevertheless, these
patients are generally recommended for invasive
testing regardless of the presence of troublesome
symptoms or clinical ﬁndings (28,29). Consequently,
MR perfusion appears most clinically useful in
patients with an intermediate pre-test probability of
CAD, as both a positive and negative test can provide
a relatively acceptable post-test probability of CAD.
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FIGURE 2 Forest Plots Illustrating Detailed Sensitivity and Speciﬁcity
The pooled sensitivity and speciﬁcity were 0.90 (95% conﬁdence interval [CI]: 0.86 to 0.93) and 0.87 (95% CI: 0.82 to 0.90), respectively, at the patient
level and 0.89 (95% CI: 0.83 to 0.92) and 0.86 (95% CI: 0.77 to 0.92), respectively, at the artery/territory level.
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tion that MR perfusion is appropriate for detecting
CAD in symptomatic patients with uninterpretable
electrocardiograms who have an intermediate pre-
test probability of CAD (30).
Several factors inﬂuencing the diagnostic perfor-
mance of FFR should be explained. FFR is an effec-
tive tool for detecting functional stenosis of the
epicardial artery and FFR-guided revascularization is
superior to QCA-guided treatment (1,2,31). However,
for patients with microvascular disease, FFR may
underestimate the degree of ischemia because the
pressure distal to the stenosis is generally affected
(32). MR perfusion also detects ischemia in the
myocardium; the decreased perfusion area presented
in MR perfusion, however, may be induced by
obstructive epicardial CAD or by abnormalmicrovascular disease (24). Although MR perfusion
may provide more information on coronary micro-
circulation than FFR, the areas with a hypointense
signal in patients with microvascular dysfunction are
frequently regarded as false positives because the
hemodynamic changes caused by the epicardial cor-
onary arteries could not be detected. More attention,
therefore, should be paid when explaining the MR
perfusion imaging in patients with potential micro-
vascular disease (33).
Additionally, artifacts, such as susceptibility arti-
facts, off-resonance artifacts, and dark-rim artifacts
(27,34,35), may inﬂuence MR perfusion accuracy.
Playing images in cine mode effectively differen-
tiates image artifacts and true perfusion defects (36).
Apart from the perfusion imaging, regional function
(wall thickening or strain imaging) analysis as well
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Probability of CAD
Magnetic resonance perfusion could increase the post-test prob-
ability of coronary artery disease (CAD) >80% in patients with a
pre-test probability of >37% and can decrease the post-test
probability of CAD<20% if the pre-test probability is<72%. LR¼
likelihood ratio.
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1103as delayed-gadolinium enhancement, which have
shown high accuracy in detecting obstructive CAD
and are generally performed simultaneously with MR
perfusion, may provide incremental information of
CAD (9,27,35). However, no data have shown that a
multicomponent examination for MR perfusion im-
proves overall accuracy to distinguish ischemic ste-
nosis. Although many technical factors, such as MR
pulse sequence, magnet strength, and data interpre-
tation, might inﬂuence the pooled results theoreti-
cally, no statistical signiﬁcance could be found, which
guarantees the pooled results of the present study.
Multivessel disease causes most CAD (37). Dis-
criminating functional stenosis at the artery/territory
level is therefore critical for determining the need
for revascularization. Our results indicate diag-
nostic performance at the artery/territory level is
even higher than at the patient level. However, the
between-study differences also increase greatly. It is
worth emphasizing that although the model was
believed to be appropriate for assigning individual
segments to speciﬁc coronary artery territories (38),
as guidelines recommend, there is still variability in
the coronary blood supply to myocardial segments(39,40), which may be the reason for the higher het-
erogeneity. Further studies with the additional anal-
ysis of adjacent segments may help improve the
clinical value of MR perfusion (39,40).
STUDY LIMITATIONS. First, we did not compare the
accuracy of MR perfusion with another myocardial
perfusion modality. Second, although numerous ef-
forts were made to contact the investigators for
additional data, not all of the included studies pro-
vided comprehensive data on the patient and artery/
territory levels. Third, studies including patients who
had undergone a previous percutaneous coronary
intervention or coronary artery bypass graft were
excluded for limited references. However, to decide
whether further treatment is required, clinical eval-
uation using MR perfusion may be necessary for those
patients (41,42). Further multicenter studies are
required to illustrate this issue more clearly. Finally,
it should be noted that the acceptable accuracy of MR
perfusion is based on FFR-guided revascularization.
Although revascularization for epicardial artery dis-
ease has become increasingly applied to relieve
symptoms and improve patient prognosis (1,2,31),
recent studies show that augmented vascular resis-
tance may occur in the coronary microcirculation
(24). The reference standard should be whether MR
perfusion is helpful for ischemia detection. This may
vary depending on whether the purpose is to detect
epicardial artery functional stenosis for revasculari-
zation, for which FFR would be the ultimate option,
or to evaluate ischemia in the myocardium for sys-
temic treatment, for which the gold standard may be
long-term follow-up. Because of the limitations of
both our review and the evidence base, further
studies at different sites with long-term follow-up as
the reference standard are needed to address the
potential of MR perfusion for use in triage to posi-
tively alter management and outcomes in patients
with suspected CAD.
CONCLUSIONS
With FFR as the reference standard, the diagnostic
ability of MR perfusion to detect ischemic CAD is high.
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